Gene · 833
Papers4,113
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 4,113
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Angiogenesis and Lymphangiogenesis in Medulloblastoma Development. | Biology (Basel) | 2023 | 37508458 | PubTator, text mining | PubMed |
| Descriptive forest: experiments on a novel tree-structure-generalization method for describing cardiovascular diseases. | BMC Med Inform Decis Mak | 2023 | 37507769 | PubTator, text mining | PubMed |
| PASCAR: a multiscale framework to explore the design space of constitutive and inducible CAR T cells. | Life Sci Alliance | 2023 | 37507138 | PubTator, text mining | PubMed |
| Update on autoantibodies and related biomarkers in autoimmune inflammatory myopathies. | Curr Opin Rheumatol | 2023 | 37503636 | PubTator, text mining | PubMed |
| CTLA-4 tail fusion enhances CAR-T antitumor immunity. | Nat Immunol | 2023 | 37500885 | PubTator, text mining | PubMed |
| Supersulphides provide airway protection in viral and chronic lung diseases. | Nat Commun | 2023 | 37491435 | PubTator, text mining | PubMed |
| CD38-Specific CAR Integrated into CD38 Locus Driven by Different Promoters Causes Distinct Antitumor Activities of T and NK Cells. | Adv Sci (Weinh) | 2023 | 37485647 | PubTator, text mining | PubMed |
| Engineering enhanced chimeric antigen receptor-T cell therapy for solid tumors. | Immunooncol Technol | 2023 | 37483659 | PubTator, text mining | PubMed |
| B7-H3-targeted CAR T cell activity is enhanced by radiotherapy in solid cancers. | Front Oncol | 2023 | 37483496 | PubTator, text mining | PubMed |
| Treatment of adult ALL patients with third-generation CD19-directed CAR T cells: results of a pivotal trial. | J Hematol Oncol | 2023 | 37481608 | PubTator, text mining | PubMed |
| Chimeric antigen receptor T cells targeting cell surface GRP78 efficiently kill glioblastoma and cancer stem cells. | J Transl Med | 2023 | 37481592 | PubTator, text mining | PubMed |
| Identification of target hub genes and construction of a novel miRNA regulatory network in autism spectrum disorder by integrated analysis. | Medicine (Baltimore) | 2023 | 37478258 | PubTator, text mining | PubMed |
| CRISPR/Cas9 as a therapeutic tool for triple negative breast cancer: from bench to clinics. | Front Mol Biosci | 2023 | 37469704 | PubTator, text mining | PubMed |
| Crosstalk between ferroptosis and steroid hormone signaling in gynecologic cancers. | Front Mol Biosci | 2023 | 37469703 | PubTator, text mining | PubMed |
| Targeting TIM-3 for hematological malignancy: latest updates from the 2022 ASH annual meeting. | Exp Hematol Oncol | 2023 | 37468979 | PubTator, text mining | PubMed |
| Differential roles of regulatory T cells in acute respiratory infections. | J Clin Invest | 2023 | 37463441 | PubTator, text mining | PubMed |
| Molecular Biomarker Identification Using a Network-Based Bioinformatics Approach That Links COVID-19 With Smoking. | Bioinform Biol Insights | 2023 | 37461741 | PubTator, text mining | PubMed |
| Novel chimeric antigen receptor T cell-based immunotherapy: a perspective for triple-negative breast cancer. | Front Cell Dev Biol | 2023 | 37457288 | PubTator, text mining | PubMed |
| Immunotherapy for advanced gastric cancer. | World J Methodol | 2023 | 37456977 | PubTator, text mining | PubMed |
| Dynamic fine-tuning of CAR-T cell therapy. | Mol Ther Oncolytics | 2023 | 37455848 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/833/papers?page=25